Direct Immunodetection of Global A-to-I RNA Editing Activity with a Chemiluminescent Bioassay.
Direct Immunodetection of Global A-to-I RNA Editing Activity with a Chemiluminescent Bioassay.
复制标题
DOI:
10.1002/anie.202102762
复制
发表时间:
2021-07-26
期刊:
影响因子:
--
通讯作者:
Heemstra JM
中科院分区:
文献类型:
--
作者:
Knutson SD;Arthur RA;Johnston HR;Heemstra JM
Adenosine-to-inosine (A-to-I) editing is a conserved eukaryotic RNA modification that contributes to development, immune response, and overall cellular function. RNA editing patterns can vary significantly between different cell and tissue types, and hyperactive A-to-I signatures are indicative of several diseases, including cancer and autoimmune disorders. Because of the biological and clinical importance of these differences, there is significant need for efficient methods to measure overall A-to-I editing levels in cellular RNA. The current standard approach relies on RNA-seq to indirectly detect editing sites, which requires significant investments in time and material as well as extensive computational analysis. Here, we utilize Endonuclease V (EndoV), which binds specifically to inosine in RNA, to develop a protein-based chemiluminescent bioassay to directly profile A-to-I RNA editing activity. We previously showed that EndoV can bind and enrich A-to-I edited transcripts prior to RNA-seq, and we now leverage this activity to construct an EndoV-linked immunosorbency assay (EndoVLISA) as a rapid, plate-based chemiluminescent method for measuring global A-to-I editing signatures in cellular RNA. We first optimize and validate our assay with chemically synthesized oligonucleotides, illustrating highly selective and sensitive detection of inosine in RNA. We then demonstrate rapid detection of inosine content in treated cell lines, demonstrating equivalent performance against current standard RNA-seq approaches. Lastly, we deploy our EndoVLISA for profiling differential A-to-I RNA editing signatures in normal and diseased human tissue, illustrating the utility of our platform as a diagnostic bioassay. Together, the EndoVLISA method is cost-effective, straightforward, and utilizes common laboratory equipment, offering a highly accessible new approach for studying A-to-I editing. Moreover, the multi-well plate format makes this the first assay amenable for direct high-throughput quantification of A-to-I editing for applications in disease detection and drug development. Adenosine-to-inosine (A-to-I) editing is a critical RNA modification and controls many cellular pathways. Dysregulation of this process is also linked with autoimmune disease, neurodegenerative disorders, and several types of cancer. Despite this importance, detecting this modification is both costly and time consuming. Here, we develop a protein-based chemiluminescent bioassay to rapidly characterize global A-to-I editing signatures in normal and diseased human tissue, addressing a significant technological need for studying RNA editing and its relationship with disease.
登录
查看更多内容
影响因子:
3.5
作者:
Galipon J;Ishii R;Suzuki Y;Tomita M;Ui-Tei K
通讯作者:
Ui-Tei K
影响因子:
14.9
作者:
Fritzell, Kajsa;Xu, Li-Di;Ohman, Marie
通讯作者:
Ohman, Marie
影响因子:
64.8
作者:
Ishizuka, Jeffrey J.;Manguso, Robert T.;Haining, W. Nicholas
通讯作者:
Haining, W. Nicholas
影响因子:
3.7
作者:
Jimmerson, Leah C.;Bushman, Lane R.;Ray, Michelle L.;Anderson, Peter L.;Kiser, Jennifer J.
通讯作者:
Kiser, Jennifer J.
影响因子:
6.2
作者:
Chowdhury B;Cho IH;Hahn N;Irudayaraj J
通讯作者:
Irudayaraj J